Efficacy of ruxolitinib in xenograft models of ETP-ALL. Peripheral blood blast count over time and splenic blast count at death in ETP-ALL xenografts. Graphed are means and standard deviations with absolute blast count on the vertical axis and days of treatment on the horizontal axis.